A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic Health

August 11, 2026 updated by: Love Wellness

This study evaluates the effects of the Love Wellness supplement Hello Burn Activate on supporting metabolic health in adult females. The 12-week, single-arm, open-label, virtual trial will enroll 40 female participants aged 25-45 who are experiencing challenges with healthy weight management and body confidence.

All participants will take one capsule of the test product daily in the morning with their first meal. Participants will complete self-reported questionnaires at Baseline, Week 4, Week 8, and Week 12 to assess changes in perceived metabolic health, body confidence, overall health, and well-being.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Nevada
      • Las Vegas, Nevada, United States, 89101
        • Citruslabs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Be female.
  • Be aged 25-45.
  • Currently experiencing issues regarding healthy weight management.
  • Currently experiencing issues regarding body confidence.
  • Currently experiencing difficulty maintaining a weight management routine.
  • Generally healthy - does not live with any uncontrolled chronic disease.
  • Willing to refrain from taking any products, prescription medications, or supplements that target metabolic health during the test period.
  • Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
  • Resides in the United States.

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period.
  • Anyone taking a prescription GLP-1 medication, including but not limited to Ozempic, Wegovy, or Mounjaro.
  • Anyone taking a prescription anticoagulant ('blood thinner') medication.
  • Anyone taking a prescription antibiotic.
  • Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
  • Anyone participating in another research study within the next 12 weeks.
  • Anyone unwilling to follow the study protocol.
  • Anyone with any allergies or sensitivities to any of the study product ingredients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hello Burn Activate
Dietary supplement: Hello Burn Activate
All enrolled participants take one capsule of Hello Burn Activate (containing heat-treated Bifidobacterium animalis lactis BPL1, inulin, vegetable capsule [hypromellose, water], and medium chain triglycerides) once daily in the morning with the first meal of the day for 12 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Perceived Metabolic Health
Time Frame: Baseline, Week 4, Week 8, and Week 12
Self-reported assessment of overall metabolic health via self-reported questionnaire
Baseline, Week 4, Week 8, and Week 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Confidence
Time Frame: Baseline, Week 4, Week 8, and Week 12
Self-reported assessment of body confidence via self-reported questionnaire
Baseline, Week 4, Week 8, and Week 12
Change in Overall Well-Being
Time Frame: Baseline, Week 4, Week 8, and Week 12
Self-reported assessment of overall well-being via self-reported questionnaire
Baseline, Week 4, Week 8, and Week 12
Change in Overall Health
Time Frame: Baseline, Week 4, Week 8, and Week 12
Self-reported assessment of overall health via self-reported questionnaire
Baseline, Week 4, Week 8, and Week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Love Wellness

Collaborators

Citruslabs

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2025

Primary Completion (Actual)

July 28, 2025

Study Completion (Actual)

July 28, 2025

Study Registration Dates

First Submitted

August 11, 2026

First Submitted That Met QC Criteria

August 11, 2026

First Posted (Actual)

August 14, 2026

Study Record Updates

Last Update Posted (Actual)

August 14, 2026

Last Update Submitted That Met QC Criteria

August 11, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 20745
  • legacy-20745

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe